The DOI matches its Crossref record.
Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
Open accessAbstract
BACKGROUND: Ventricular tachyarrhythmias are the major clinical manifestation of arrhythmogenic right ventricular disease. Although antiarrhythmic therapy has been widely advocated, there is only limited information available on the efficacy of antiarrhythmic drugs in these patients. METHODS AND RESULTS: The short- and long-term efficacies of various antiarrhythmic agents were retrospectively and prospectively analyzed in 81 patients (mean age, 39 +/- 14 years; range, 16-68 years; 61.7% males) with arrhythmogenic right ventricular disease. In 42 patients with inducible ventricular tachycardia during programmed ventricular stimulation, the following efficacy rates were obtained: class Ia and Ib drugs (n = 18), 5.6%; class Ic drugs (n = 25), 12%; beta-blockers (n = 8), 0%; sotalol (n = 38), 68.4%; amiodarone (n = 13), 15.4%; verapamil (n = 5), 0%; and drug combinations (n = 26), 15.4%. Only one of the 10 patients not responding to sotalol was treated effectively by amiodarone, whereas the remaining nine patients proved to be drug refractory toward all other drugs tested (3.8 +/- 2.3 drugs, including amiodarone in five cases) and underwent nonpharmacological therapy. During a follow-up of 34 +/- 25 months, three of the 31 patients (9.7%) discharged on pharmacological therapy had nonfatal recurrences of ventricular tachycardia after 0.5, 51, and 63 months, respectively. In 39 patients with noninducible ventricular tachycardia during programmed ventricular stimulation, the following efficacy rates were observed: class Ia and Ib drugs (n = 16), 0%; class Ic agents (n = 23), 17.4%; beta-blockers (n = 7), 28.6%; sotalol (n = 35), 82.8%; amiodarone (n = 4), 25%; verapamil (n = 24), 50%; and drug combinations (n = 11), 9.1%. During a follow-up of 14 +/- 13 months, four of 33 patients (12.1%) discharged on antiarrhythmic drugs had nonfatal relapses of their clinical ventricular arrhythmia. CONCLUSIONS: Thus, in arrhythmogenic right ventricular disease, sotalol proved to be highly effective in patients with inducible as well as noninducible ventricular tachycardia. Patients with inducible ventricular tachycardia not responding to sotalol are likely to not respond to other antiarrhythmic drugs and should be considered for nonpharmacological therapy without further drug testing. Amiodarone did not prove to be more effective than sotalol and may not be an alternative because of frequent side effects during long-term therapy, especially in young patients. Verapamil and beta-blockers were effective in a considerable number of patients with noninducible ventricular tachycardia and may be a therapeutic alternative in this subgroup. Class I agents appear to be rarely effective in the treatment of both inducible and noninducible ventricular tachycardia in arrhythmogenic right ventricular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Self-citationZeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Arrhythmogenic right ventricular cardiomyopathy
Basso, C., Corrado, D., Marcus, F. I., Nava, A., & Thiene, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60256-7 · Cited by 931
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 903
Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias
Shen, M. J., & Zipes, D. P. (2014) · Circulation Research · doi:10.1161/circresaha.113.302549 · Cited by 867
Arrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Corrado, D., Wichter, T., Link, M. S., Hauer, R. N. W., Marchlinski, F. E., Anastasakis, A., Bauce, B., Basso, C., Brunckhorst, C., Tsatsopoulou, A., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017944 · Cited by 513
Self-citation2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al-Khatib, S. M., Anter, E., et al. (2019) · EP Europace · doi:10.1093/europace/euz132 · Cited by 475
Nava, A., Bauce, B., Basso, C., Muriago, M., Rampazzo, A., Villanova, C., Daliento, L., Buja, G., Corrado, D., Danieli, G. A., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00997-9 · Cited by 461
Corrado, D., Basso, C., & Judge, D. P. (2017) · Circulation Research · doi:10.1161/circresaha.117.309345 · Cited by 452
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al-Khatib, S. M., Anter, E., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.002 · Cited by 431
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Need for an International Registry
Corrado, D., Fontaine, G., Marcus, F. I., McKenna, W. J., Nava, A., Thiene, G., & Wichter, T. (2000) · Circulation · doi:10.1161/01.cir.101.11.e101 · Cited by 337
Self-citationCorrado, D., Calkins, H., Link, M. S., Leoni, L., Favale, S., Bevilacqua, M., Basso, C., Ward, D., Boriani, G., Ricci, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.913871 · Cited by 306
Self-citationWichter, T., Paul, M., Wollmann, C., Acil, T., Gerdes, P., Ashraf, O., Tjan, T. D. T., Soeparwata, R., Block, M., Borggrefe, M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000121738.88273.43 · Cited by 294
Self-citationArrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment
Corrado, D., Basso, C., & Thiene, G. (2000) · Heart · doi:10.1136/heart.83.5.588 · Cited by 286
Arrhythmogenic right ventricular cardiomyopathy/dysplasia
Thiene, G., Corrado, D., & Basso, C. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-45 · Cited by 283
Corrado, D., Wichter, T., Link, M. S., Hauer, R., Marchlinski, F., Anastasakis, A., Bauce, B., Basso, C., Brunckhorst, C., Tsatsopoulou, A., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv162 · Cited by 265
Self-citationArrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Review
MARCUS, F. I., & FONTAINE, G. (1995) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1995.tb06971.x · Cited by 256
Pathophysiology of arrhythmogenic cardiomyopathy
Basso, C., Bauce, B., Corrado, D., & Thiene, G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.173 · Cited by 253
Ermakov, S., Gerstenfeld, E. P., Svetlichnaya, Y., & Scheinman, M. M. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2016.12.010 · Cited by 94
Gaine, S., Rolland, T., Asatryan, B., Laredo, M., Sampognaro, J., Carrick, R. T., Peretto, G., Muller, S., Villatore, A., Murray, B., et al. (2025) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2025.02.023 · Cited by 14
Metadata
- Authors
- Wichter, T., Borggrefe, M., Haverkamp, W., Chen, X., & Breithardt, G.
- Venue
- Circulation
- Published
- 1992-07
- Volume
- 86
- Issue
- 1
- Pages
- 29-37
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983486304
- Cited by
- 314
- References
- 0
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.